Investors

Management team

Management team

Fredrik Brag

CEO, Chairman and Co-founder

Fredrik Brag

CEO, Chairman and Co-founder

Fredrik Brag is Median’s Chief Executive and Chairman of the Board of Directors. He co-founded the company in 2002, bringing years of technology company expertise gained in business development, fund raising and IPOs. He was previously Vice President of HealthCenter / Focus Imaging, where he built significant experience in specialized medical imaging and information and communication technology. He is graduate of the Stockholm School of Economics.

Previous
Next

Jeanne Hecht

Chief Operating Officer

Jeanne Hecht

Chief Operating Officer

Jeanne Hecht joined Median Technologies as Chief Operating Officer and member of the Board in 2016, bringing more than 20 years’ experience of the healthcare industry.  She is responsible for driving the company’s global strategy, including management of operations, sales as well as new product development.  Prior to joining Median, she held a number of senior roles at industry-leading contract research organization, Quintiles. Most recently, she was Senior Vice President of Site & Patient Networks, having previously served as Global Head of Sales.  She also led Quintiles Asia Sales and Strategic Planning team and served as Vice President, Strategic Accounts. Previously, she was cofounder and Vice President of Sales and Marketing for a biomarker-based companion diagnostic company. She earned her Master of Business Administration and Bachelor’s degree in biology from the University of Michigan.

Jeanne is very active in her community and serves on the Industry Advisory Board at the University of North Carolina’s Kenan Flagler Business School.

Previous
Next

Nicholas Campbell

Chief Commercial Officer

Nicholas Campbell

Chief Commercial Officer

Nicholas Campbell joined Median Technologies as Chief Commercial Officer in 2016, and is responsible for all commercial activities across the organization.  He brings nearly 20 years’ international experience of the biopharmaceutical industry, gained in sales, market building, and strategic partnering in the US, EU, and Asia. Previously, he served as Vice President and Managing Director in Quintiles’ Customer Solutions Management Group. He also held leadership positions as Global Head of Sales for Quintiles’ Early Clinical, Cardiac Safety and Genomic Service businesses and was Head of Sales for Quintiles East Asia. He holds a Bachelor of Science from the University of Wolverhampton, UK and a Master of Business Administration from the University of Plymouth Business School, UK.

Previous
Next

Peter Bannister

Chief Technology Officer

Peter Bannister

Chief Technology Officer

Dr. Peter Bannister joined Median in 2017 as Chief Technology Officer, bringing more than 15 years of experience developing novel imaging products. As Chief Technology Officer, Dr. Bannister is responsible for leading the development and scientific research teams at Median and ensuring that Median’s products directly address the unmet healthcare needs identified by the company’s clinical end users. Dr. Bannister has held senior executive positions in multiple high-tech university spin-outs. He holds a DPhil (PhD) from the University of Oxford, where he was one of the original developers of the Functional MRI of the Brain (FMRIB) Software Library for image analysis. Subsequently he held a post-doctoral research appointment in machine learning for complex industrial systems in collaboration with Rolls-Royce Plc.

He also taught engineering science at Oxford for over a decade and remains a passionate advocate for education and professional development across the STEM (Science, Technology, Engineering, Mathematics) subjects. Peter is a Chartered Engineer and is Executive Chairman of the Institute of Engineering and Technology’s Healthcare Sector

Previous
Next

Loan Hoang-Sayad

Chief Medical Officer

Loan Hoang-Sayad

Chief Medical Officer

Loan Hoang-Sayag, MD joined Median as Chief Medical Officer in 2017. She oversees the global clinical vision and medical strategy of the company and works closely with Median’s scientific advisors. She supports all company business segments on medical and regulatory aspects and provides a clinical perspective to all activities of the company. Dr. Hoang-Sayag is board-certified in hematology and medical oncology from Necker-Paris V René Descartes University and St-Antoine- Paris VI University, respectively. Dr. Hoang-Sayag has over 25 years of hematology and oncology experience within the clinical and academic settings and over 17 years of experience leading oncology drug development.

Dr. Hoang-Sayag started her industry career at Hoffmann-La Roche where she was responsible for clinical development and medical affairs activities for different oncology drugs.  Following this post, she held roles at both Pierre Fabre Oncology and Quintiles where she led oncology development programs and the European Oncology Medical team, respectively. Most recently, she served as the Chief Medical Officer at Cellectis.

Previous
Next

Bernard Reymann

Chief Financial Officer

Bernard Reymann

Chief Financial Officer

Bernard Reymann has over 25 years of experience in finance departments of major international industry groups, international SME and startups. Prior to joining MEDIAN, he was chief financial officer and acting executive committee member at Tekka Group SA (2011-2012), Varioptic SA (2004-2011), and Temex Group SA (1989-2004). Bernard Reymann graduated from the European Institute for Higher Business Studies (IECS), Strasbourg, and holds a master’s degree from the Institute of High Finance (IHF), Paris.

Previous
Next

James Golando

Chief of Operations

James Golando

Chief of Operations

James Golando joined Median in 2016 as Chief of Operations. He manages the company’s Global Operations, including Project Management, Data Management, Imaging and Site Management Services. James brings over 25 years of experience of the healthcare industry, gained at a number of pharmaceutical and biotechnology companies.

Prior to joining Median, he served as Senior Vice President, Head of Global Operations and Pharmacovigilance at Piramal Healthcare. Previously, he held clinical research, clinical operations and vendor management roles at Hoffman-La Roche, Schering-Plough and Novartis, and has 10 years’ experience in the clinical imaging business as Vice President of Global Operations at Radpharm and CoreLab Partners.

Previous
Next

Cookies help us deliver our services. By using our services, you agree to our use of cookies.